Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2

Detalhes bibliográficos
Autor(a) principal: Estomba,Carlos Miguel Chiesa
Data de Publicação: 2016
Outros Autores: Reinoso,Frank Alberto Betances, Velasquez,Alejandra Osorio, Fernandez,Jose Luis Rodriguez, Conde,Jose Luis Fariña, Hidalgo,Carmelo Santidrian
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Archives of Otorhinolaryngology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642016000300212
Resumo: Abstract Introduction Transoral laser microsurgery (TLM) has won territory in larynx oncology, establishing itself as an effective option in treatment of glottic, supraglottic, and hypopharynx tumors. Its advantages include limited resections, a reduction in number of tracheostomies, and the use of nasogastric tubes. Moreover, its oncological benefits are similar to those from open surgery in patients with early or advanced stages, when correctly selected. Objective The objective of this study is to review oncologic outcomes obtained with the treatment of a series of glottic tumors, treated by TLM. Methods Retrospective analysis of patients previously untreated, diagnosed with squamous cell carcinoma of the glottis (T1a, T1b, T2) in a tertiary university hospital. Endpoints for analysis were local control, overall and disease-specific survival, and larynx preservation rate. Results The study group included 58 patients that met the inclusion criteria: 57 (98.3%) men and 1 (1.7%) woman. Mean age was 65.5 10.7 years (Min: 46/Max: 88). The tumor stages of the patients included were 30 T1a, 11 (19%) T1b, and 17 (29.3%) T2. Three-year overall survival rate was 89.7% (Fig. 1), and three-year disease-specific survival rate was 96.5%, three-year local control rate was 98.3%, and three-year organ preservation rate was 98.3%. Conclusion TLM is a safe and effective option in the treatment of glottis carcinomas, associated with less morbidity and a high percentage of local control, overall survival, specific survival, and organ preservation.
id FORL-1_87400f4366e24de646527d8814496aa3
oai_identifier_str oai:scielo:S1809-48642016000300212
network_acronym_str FORL-1
network_name_str International Archives of Otorhinolaryngology
repository_id_str
spelling Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2larynxCO2 lasercarcinomaAbstract Introduction Transoral laser microsurgery (TLM) has won territory in larynx oncology, establishing itself as an effective option in treatment of glottic, supraglottic, and hypopharynx tumors. Its advantages include limited resections, a reduction in number of tracheostomies, and the use of nasogastric tubes. Moreover, its oncological benefits are similar to those from open surgery in patients with early or advanced stages, when correctly selected. Objective The objective of this study is to review oncologic outcomes obtained with the treatment of a series of glottic tumors, treated by TLM. Methods Retrospective analysis of patients previously untreated, diagnosed with squamous cell carcinoma of the glottis (T1a, T1b, T2) in a tertiary university hospital. Endpoints for analysis were local control, overall and disease-specific survival, and larynx preservation rate. Results The study group included 58 patients that met the inclusion criteria: 57 (98.3%) men and 1 (1.7%) woman. Mean age was 65.5 10.7 years (Min: 46/Max: 88). The tumor stages of the patients included were 30 T1a, 11 (19%) T1b, and 17 (29.3%) T2. Three-year overall survival rate was 89.7% (Fig. 1), and three-year disease-specific survival rate was 96.5%, three-year local control rate was 98.3%, and three-year organ preservation rate was 98.3%. Conclusion TLM is a safe and effective option in the treatment of glottis carcinomas, associated with less morbidity and a high percentage of local control, overall survival, specific survival, and organ preservation.Fundação Otorrinolaringologia2016-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642016000300212International Archives of Otorhinolaryngology v.20 n.3 2016reponame:International Archives of Otorhinolaryngologyinstname:Fundação Otorrinolaringologia (FORL)instacron:FORL10.1055/s-0036-1572430info:eu-repo/semantics/openAccessEstomba,Carlos Miguel ChiesaReinoso,Frank Alberto BetancesVelasquez,Alejandra OsorioFernandez,Jose Luis RodriguezConde,Jose Luis FariñaHidalgo,Carmelo Santidrianeng2016-09-02T00:00:00Zoai:scielo:S1809-48642016000300212Revistahttps://www.scielo.br/j/iao/https://old.scielo.br/oai/scielo-oai.php||iaorl@iaorl.org||archives@internationalarchivesent.org||arquivos@forl.org.br1809-48641809-4864opendoar:2016-09-02T00:00International Archives of Otorhinolaryngology - Fundação Otorrinolaringologia (FORL)false
dc.title.none.fl_str_mv Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2
title Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2
spellingShingle Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2
Estomba,Carlos Miguel Chiesa
larynx
CO2 laser
carcinoma
title_short Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2
title_full Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2
title_fullStr Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2
title_full_unstemmed Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2
title_sort Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2
author Estomba,Carlos Miguel Chiesa
author_facet Estomba,Carlos Miguel Chiesa
Reinoso,Frank Alberto Betances
Velasquez,Alejandra Osorio
Fernandez,Jose Luis Rodriguez
Conde,Jose Luis Fariña
Hidalgo,Carmelo Santidrian
author_role author
author2 Reinoso,Frank Alberto Betances
Velasquez,Alejandra Osorio
Fernandez,Jose Luis Rodriguez
Conde,Jose Luis Fariña
Hidalgo,Carmelo Santidrian
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Estomba,Carlos Miguel Chiesa
Reinoso,Frank Alberto Betances
Velasquez,Alejandra Osorio
Fernandez,Jose Luis Rodriguez
Conde,Jose Luis Fariña
Hidalgo,Carmelo Santidrian
dc.subject.por.fl_str_mv larynx
CO2 laser
carcinoma
topic larynx
CO2 laser
carcinoma
description Abstract Introduction Transoral laser microsurgery (TLM) has won territory in larynx oncology, establishing itself as an effective option in treatment of glottic, supraglottic, and hypopharynx tumors. Its advantages include limited resections, a reduction in number of tracheostomies, and the use of nasogastric tubes. Moreover, its oncological benefits are similar to those from open surgery in patients with early or advanced stages, when correctly selected. Objective The objective of this study is to review oncologic outcomes obtained with the treatment of a series of glottic tumors, treated by TLM. Methods Retrospective analysis of patients previously untreated, diagnosed with squamous cell carcinoma of the glottis (T1a, T1b, T2) in a tertiary university hospital. Endpoints for analysis were local control, overall and disease-specific survival, and larynx preservation rate. Results The study group included 58 patients that met the inclusion criteria: 57 (98.3%) men and 1 (1.7%) woman. Mean age was 65.5 10.7 years (Min: 46/Max: 88). The tumor stages of the patients included were 30 T1a, 11 (19%) T1b, and 17 (29.3%) T2. Three-year overall survival rate was 89.7% (Fig. 1), and three-year disease-specific survival rate was 96.5%, three-year local control rate was 98.3%, and three-year organ preservation rate was 98.3%. Conclusion TLM is a safe and effective option in the treatment of glottis carcinomas, associated with less morbidity and a high percentage of local control, overall survival, specific survival, and organ preservation.
publishDate 2016
dc.date.none.fl_str_mv 2016-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642016000300212
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642016000300212
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1055/s-0036-1572430
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Fundação Otorrinolaringologia
publisher.none.fl_str_mv Fundação Otorrinolaringologia
dc.source.none.fl_str_mv International Archives of Otorhinolaryngology v.20 n.3 2016
reponame:International Archives of Otorhinolaryngology
instname:Fundação Otorrinolaringologia (FORL)
instacron:FORL
instname_str Fundação Otorrinolaringologia (FORL)
instacron_str FORL
institution FORL
reponame_str International Archives of Otorhinolaryngology
collection International Archives of Otorhinolaryngology
repository.name.fl_str_mv International Archives of Otorhinolaryngology - Fundação Otorrinolaringologia (FORL)
repository.mail.fl_str_mv ||iaorl@iaorl.org||archives@internationalarchivesent.org||arquivos@forl.org.br
_version_ 1754203975596376064